{"protocolSection": {"identificationModule": {"nctId": "NCT01368081", "orgStudyIdInfo": {"id": "1245.52"}, "organization": {"fullName": "Boehringer Ingelheim", "class": "INDUSTRY"}, "briefTitle": "Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With Type 2 Diabetes Mellitus", "officialTitle": "A 52-week, Randomised, Multi-centre, Parallel Group Study to Investigate the Safety and Efficacy of BI 10773 (10 mg or 25 mg Administered Orally Once Daily) as add-on Therapy to an Oral Antidiabetic Drug (Sulfonylurea, Biguanide, Thiazolidinedione, Alpha Glucosidase Inhibitor, DPP-IV Inhibitor, or Glinide) in Patients With Type 2 Diabetes Mellitus With Insufficient Glycaemic Control"}, "statusModule": {"statusVerifiedDate": "2014-05", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2011-05"}, "primaryCompletionDateStruct": {"date": "2013-04", "type": "ACTUAL"}, "completionDateStruct": {"date": "2013-04", "type": "ACTUAL"}, "studyFirstSubmitDate": "2011-05-19", "studyFirstSubmitQcDate": "2011-06-06", "studyFirstPostDateStruct": {"date": "2011-06-07", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2014-05-16", "resultsFirstSubmitQcDate": "2014-05-16", "resultsFirstPostDateStruct": {"date": "2014-06-17", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2014-05-16", "lastUpdatePostDateStruct": {"date": "2014-06-17", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Boehringer Ingelheim", "class": "INDUSTRY"}, "collaborators": [{"name": "Eli Lilly and Company", "class": "INDUSTRY"}]}, "descriptionModule": {"briefSummary": "The objective of the study is to investigate the long-term safety and efficacy of BI 10773 given for 52 weeks as add-on therapy to one oral antidiabetic drug in patients with type 2 diabetes mellitus with insufficient glycaemic control."}, "conditionsModule": {"conditions": ["Diabetes Mellitus, Type 2"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "DOUBLE"}}, "enrollmentInfo": {"count": 1162, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "BI 10773 low dose", "type": "EXPERIMENTAL", "description": "BI 10773 low dose tablet once daily", "interventionNames": ["Drug: BI 10773", "Drug: Placebo (high dose)"]}, {"label": "BI 10773 high dose", "type": "EXPERIMENTAL", "description": "BI 10773 high dose tablet once daily", "interventionNames": ["Drug: Placebo (low dose)", "Drug: BI 10773"]}, {"label": "Metformin", "type": "ACTIVE_COMPARATOR", "description": "Metformin tablets 500-2250 mg a day (twice or three times per day)", "interventionNames": ["Drug: Metformin"]}], "interventions": [{"type": "DRUG", "name": "Metformin", "description": "Metformin tablets 500-2250 mg a day (twice or three times per day)", "armGroupLabels": ["Metformin"]}, {"type": "DRUG", "name": "BI 10773", "description": "BI 10773 low dose tablet once daily", "armGroupLabels": ["BI 10773 low dose"]}, {"type": "DRUG", "name": "Placebo (low dose)", "description": "Placebo tablets once daily", "armGroupLabels": ["BI 10773 high dose"]}, {"type": "DRUG", "name": "BI 10773", "description": "BI 10773 high dose tablet once daily", "armGroupLabels": ["BI 10773 high dose"]}, {"type": "DRUG", "name": "Placebo (high dose)", "description": "Placebo tablets once daily", "armGroupLabels": ["BI 10773 low dose"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Number of Patients With Drug Related Adverse Events", "description": "Number of Patients With Drug Related Adverse Events after the first drug intake until 7 days after the last treatment administration, up to 383 days", "timeFrame": "After the first drug intake until 7 days after the last treatment administration, up to 383 days"}], "secondaryOutcomes": [{"measure": "Change From Baseline in HbA1c", "description": "Change from baseline in HbA1c after 52 weeks of treatment", "timeFrame": "Baseline and 52 weeks"}], "otherOutcomes": [{"measure": "Confirmed Hypoglycaemic Adverse Events", "description": "Number of patients with confirmed hypoglycaemic adverse events", "timeFrame": "After the first drug intake until 7 days after the last treatment administration, up to 383 days"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion criteria:\n\n* .Diagnosis of type 2 diabetes mellitus prior to informed consent\n* Male and female patients, on diet and exercise regimen, who are pre-treated with one of the following oral antidiabetic drugs: sulfonylurea, glinide, biguanide, Alpha-glucosidase inhibitor (a-GI), dipeptidyl peptidase-IV (DPP-IV) inhibitor or thiazolidinedione\n* glycosylated haemoglobin (HbA1c) at Visit 1: \\>=7.0 to =\\<10.0% (national glycohemoglobin standardization program)\n\nExclusion criteria:\n\n* Uncontrolled hyperglycaemia with a glucose level \\>240 mg/dL (\\>13.3 mmol/L)\n* Acute coronary syndrome, stroke or transient ischemic attack (TIA) within 12 weeks prior to informed consent\n* Indication of liver disease, defined by serum levels of either alanine transaminase (ALT), aspartate transaminase (AST), or alkaline phosphatase (ALP) above 3 x upper limit of normal (ULN)", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "20 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Boehringer Ingelheim", "affiliation": "Boehringer Ingelheim", "role": "STUDY_CHAIR"}], "locations": [{"facility": "1245.52.023 Boehringer Ingelheim Investigational Site", "city": "Adachi-ku, Tokyo", "country": "Japan"}, {"facility": "1245.52.048 Boehringer Ingelheim Investigational Site", "city": "Aki-gun, Hiroshima", "country": "Japan"}, {"facility": "1245.52.012 Boehringer Ingelheim Investigational Site", "city": "Annaka, Gunma", "country": "Japan"}, {"facility": "1245.52.087 Boehringer Ingelheim Investigational Site", "city": "Atami, Shizuoka", "country": "Japan"}, {"facility": "1245.52.008 Boehringer Ingelheim Investigational Site", "city": "Beppu, Oita", "country": "Japan"}, {"facility": "1245.52.073 Boehringer Ingelheim Investigational Site", "city": "Chiyoda-ku, Tokyo", "country": "Japan"}, {"facility": "1245.52.002 Boehringer Ingelheim Investigational Site", "city": "Chuo-ku, Tokyo", "country": "Japan", "geoPoint": {"lat": 35.57779, "lon": 139.71685}}, {"facility": "1245.52.020 Boehringer Ingelheim Investigational Site", "city": "Chuo-ku, Tokyo", "country": "Japan", "geoPoint": {"lat": 35.57779, "lon": 139.71685}}, {"facility": "1245.52.021 Boehringer Ingelheim Investigational Site", "city": "Chuo-ku, Tokyo", "country": "Japan", "geoPoint": {"lat": 35.57779, "lon": 139.71685}}, {"facility": "1245.52.031 Boehringer Ingelheim Investigational Site", "city": "Fujisawa, Kanagawa", "country": "Japan"}, {"facility": "1245.52.077 Boehringer Ingelheim Investigational Site", "city": "Fukuoka, Fukuoka", "country": "Japan", "geoPoint": {"lat": 33.6, "lon": 130.41667}}, {"facility": "1245.52.086 Boehringer Ingelheim Investigational Site", "city": "Hadano, Kanagawa", "country": "Japan"}, {"facility": "1245.52.037 Boehringer Ingelheim Investigational Site", "city": "Hamamatsu, Shizuoka", "country": "Japan"}, {"facility": "1245.52.046 Boehringer Ingelheim Investigational Site", "city": "Himeji, Hyogo", "country": "Japan"}, {"facility": "1245.52.047 Boehringer Ingelheim Investigational Site", "city": "Hiroshima, Hiroshima", "country": "Japan", "geoPoint": {"lat": 34.4, "lon": 132.45}}, {"facility": "1245.52.051 Boehringer Ingelheim Investigational Site", "city": "Imabari, Ehime", "country": "Japan"}, {"facility": "1245.52.016 Boehringer Ingelheim Investigational Site", "city": "Iruma,Saitama", "country": "Japan"}, {"facility": "1245.52.033 Boehringer Ingelheim Investigational Site", "city": "Isehara, Kanagawa", "country": "Japan"}, {"facility": "1245.52.011 Boehringer Ingelheim Investigational Site", "city": "Isesaki, Gunma", "country": "Japan"}, {"facility": "1245.52.045 Boehringer Ingelheim Investigational Site", "city": "Izumisano,Osaka", "country": "Japan"}, {"facility": "1245.52.088 Boehringer Ingelheim Investigational Site", "city": "Kamakura, Kanagawa", "country": "Japan"}, {"facility": "1245.52.072 Boehringer Ingelheim Investigational Site", "city": "Kamakura,Kanagawa", "country": "Japan"}, {"facility": "1245.52.034 Boehringer Ingelheim Investigational Site", "city": "Kanazawa, Ishikawa", "country": "Japan"}, {"facility": "1245.52.058 Boehringer Ingelheim Investigational Site", "city": "Kanoya, Kagoshima", "country": "Japan"}, {"facility": "1245.52.019 Boehringer Ingelheim Investigational Site", "city": "Kashiwa, Chiba", "country": "Japan"}, {"facility": "1245.52.039 Boehringer Ingelheim Investigational Site", "city": "Kasugai, Aichi", "country": "Japan"}, {"facility": "1245.52.027 Boehringer Ingelheim Investigational Site", "city": "Kawasaki, Kanagawa", "country": "Japan"}, {"facility": "1245.52.018 Boehringer Ingelheim Investigational Site", "city": "Kita-adachi-gun, Saitama", "country": "Japan"}, {"facility": "1245.52.022 Boehringer Ingelheim Investigational Site", "city": "Kita-ku, Tokyo", "country": "Japan"}, {"facility": "1245.52.052 Boehringer Ingelheim Investigational Site", "city": "Kitakyushu, Fukuoka", "country": "Japan"}, {"facility": "1245.52.076 Boehringer Ingelheim Investigational Site", "city": "Kobe, Hyogo", "country": "Japan"}, {"facility": "1245.52.026 Boehringer Ingelheim Investigational Site", "city": "Kodaira, Tokyo", "country": "Japan"}, {"facility": "1245.52.069 Boehringer Ingelheim Investigational Site", "city": "Koriyama, Fukushima", "country": "Japan"}, {"facility": "1245.52.071 Boehringer Ingelheim Investigational Site", "city": "Koriyama, Fukushima", "country": "Japan"}, {"facility": "1245.52.014 Boehringer Ingelheim Investigational Site", "city": "Koshigaya, Saitama", "country": "Japan"}, {"facility": "1245.52.074 Boehringer Ingelheim Investigational Site", "city": "Kuki, Saitama", "country": "Japan"}, {"facility": "1245.52.055 Boehringer Ingelheim Investigational Site", "city": "Kumamoto, Kumamoto", "country": "Japan", "geoPoint": {"lat": 32.80589, "lon": 130.69182}}, {"facility": "1245.52.049 Boehringer Ingelheim Investigational Site", "city": "Kure, Hiroshima", "country": "Japan"}, {"facility": "1245.52.040 Boehringer Ingelheim Investigational Site", "city": "Kyoto, Kyoto", "country": "Japan", "geoPoint": {"lat": 35.02107, "lon": 135.75385}}, {"facility": "1245.52.010 Boehringer Ingelheim Investigational Site", "city": "Maebashi, Gunma", "country": "Japan"}, {"facility": "1245.52.080 Boehringer Ingelheim Investigational Site", "city": "Maebashi, Gunma", "country": "Japan"}, {"facility": "1245.52.050 Boehringer Ingelheim Investigational Site", "city": "Matsuyama, Ehime", "country": "Japan"}, {"facility": "1245.52.075 Boehringer Ingelheim Investigational Site", "city": "Meguro-ku, Tokyo", "country": "Japan"}, {"facility": "1245.52.056 Boehringer Ingelheim Investigational Site", "city": "Miyazaki, Miyazaki", "country": "Japan"}, {"facility": "1245.52.057 Boehringer Ingelheim Investigational Site", "city": "Miyazaki, Miyazaki", "country": "Japan"}, {"facility": "1245.52.079 Boehringer Ingelheim Investigational Site", "city": "Morioka, Iwate", "country": "Japan"}, {"facility": "1245.52.003 Boehringer Ingelheim Investigational Site", "city": "Nagoya, Aichi", "country": "Japan", "geoPoint": {"lat": 35.18147, "lon": 136.90641}}, {"facility": "1245.52.004 Boehringer Ingelheim Investigational Site", "city": "Nagoya, Aichi", "country": "Japan", "geoPoint": {"lat": 35.18147, "lon": 136.90641}}, {"facility": "1245.52.005 Boehringer Ingelheim Investigational Site", "city": "Nagoya, Aichi", "country": "Japan", "geoPoint": {"lat": 35.18147, "lon": 136.90641}}, {"facility": "1245.52.038 Boehringer Ingelheim Investigational Site", "city": "Nagoya, Aichi", "country": "Japan", "geoPoint": {"lat": 35.18147, "lon": 136.90641}}, {"facility": "1245.52.059 Boehringer Ingelheim Investigational Site", "city": "Naha, Okinawa", "country": "Japan"}, {"facility": "1245.52.066 Boehringer Ingelheim Investigational Site", "city": "Naha, Okinawa", "country": "Japan"}, {"facility": "1245.52.065 Boehringer Ingelheim Investigational Site", "city": "Nanjyo, Okinawa", "country": "Japan"}, {"facility": "1245.52.007 Boehringer Ingelheim Investigational Site", "city": "Oita, Oita", "country": "Japan"}, {"facility": "1245.52.053 Boehringer Ingelheim Investigational Site", "city": "Okawa, Fukuoka", "country": "Japan"}, {"facility": "1245.52.068 Boehringer Ingelheim Investigational Site", "city": "Okinawa, Okinawa", "country": "Japan"}, {"facility": "1245.52.042 Boehringer Ingelheim Investigational Site", "city": "Osaka,Osaka", "country": "Japan", "geoPoint": {"lat": 34.69374, "lon": 135.50218}}, {"facility": "1245.52.089 Boehringer Ingelheim Investigational Site", "city": "Osaki, Miyagi", "country": "Japan"}, {"facility": "1245.52.024 Boehringer Ingelheim Investigational Site", "city": "Ota-ku, Tokyo", "country": "Japan"}, {"facility": "1245.52.054 Boehringer Ingelheim Investigational Site", "city": "Saga, Saga", "country": "Japan"}, {"facility": "1245.52.032 Boehringer Ingelheim Investigational Site", "city": "Sagamihara, Kanagawa", "country": "Japan"}, {"facility": "1245.52.085 Boehringer Ingelheim Investigational Site", "city": "Sagamihara, Kanagawa", "country": "Japan"}, {"facility": "1245.52.013 Boehringer Ingelheim Investigational Site", "city": "Saitama, Saitama", "country": "Japan"}, {"facility": "1245.52.015 Boehringer Ingelheim Investigational Site", "city": "Sakado, Saitama", "country": "Japan"}, {"facility": "1245.52.044 Boehringer Ingelheim Investigational Site", "city": "Sakai, Osaka", "country": "Japan"}, {"facility": "1245.52.035 Boehringer Ingelheim Investigational Site", "city": "Saku, Nagano", "country": "Japan"}, {"facility": "1245.52.009 Boehringer Ingelheim Investigational Site", "city": "Sapporo, Hokkaido", "country": "Japan", "geoPoint": {"lat": 43.06667, "lon": 141.35}}, {"facility": "1245.52.025 Boehringer Ingelheim Investigational Site", "city": "Setagaya-ku, Tokyo", "country": "Japan", "geoPoint": {"lat": 35.64825, "lon": 139.65376}}, {"facility": "1245.52.063 Boehringer Ingelheim Investigational Site", "city": "Shimajiri-gun, Okinawa", "country": "Japan"}, {"facility": "1245.52.064 Boehringer Ingelheim Investigational Site", "city": "Shimajiri-gun, Okinawa", "country": "Japan"}, {"facility": "1245.52.001 Boehringer Ingelheim Investigational Site", "city": "Shinjuku-ku. Tokyo", "country": "Japan", "geoPoint": {"lat": 35.2946, "lon": 139.57059}}, {"facility": "1245.52.036 Boehringer Ingelheim Investigational Site", "city": "Shizuoka, Shizuoka", "country": "Japan"}, {"facility": "1245.52.006 Boehringer Ingelheim Investigational Site", "city": "Suita, Osaka", "country": "Japan"}, {"facility": "1245.52.043 Boehringer Ingelheim Investigational Site", "city": "Takatsuki, Osaka", "country": "Japan"}, {"facility": "1245.52.017 Boehringer Ingelheim Investigational Site", "city": "Tokorozawa, Saitama", "country": "Japan"}, {"facility": "1245.52.070 Boehringer Ingelheim Investigational Site", "city": "Tokorozawa, Saitama", "country": "Japan"}, {"facility": "1245.52.061 Boehringer Ingelheim Investigational Site", "city": "Tomigusuku, Okinawa", "country": "Japan"}, {"facility": "1245.52.062 Boehringer Ingelheim Investigational Site", "city": "Tomigusuku, Okinawa", "country": "Japan"}, {"facility": "1245.52.041 Boehringer Ingelheim Investigational Site", "city": "Uji, Kyoto", "country": "Japan"}, {"facility": "1245.52.067 Boehringer Ingelheim Investigational Site", "city": "Uruma, Okinawa", "country": "Japan"}, {"facility": "1245.52.028 Boehringer Ingelheim Investigational Site", "city": "Yokohama, Kanagawa", "country": "Japan", "geoPoint": {"lat": 35.43333, "lon": 139.65}}, {"facility": "1245.52.029 Boehringer Ingelheim Investigational Site", "city": "Yokohama, Kanagawa", "country": "Japan", "geoPoint": {"lat": 35.43333, "lon": 139.65}}, {"facility": "1245.52.030 Boehringer Ingelheim Investigational Site", "city": "Yokohama, Kanagawa", "country": "Japan", "geoPoint": {"lat": 35.43333, "lon": 139.65}}, {"facility": "1245.52.081 Boehringer Ingelheim Investigational Site", "city": "Yokohama, Kanagawa", "country": "Japan", "geoPoint": {"lat": 35.43333, "lon": 139.65}}, {"facility": "1245.52.082 Boehringer Ingelheim Investigational Site", "city": "Yokohama, Kanagawa", "country": "Japan", "geoPoint": {"lat": 35.43333, "lon": 139.65}}, {"facility": "1245.52.083 Boehringer Ingelheim Investigational Site", "city": "Yokohama, Kanagawa", "country": "Japan", "geoPoint": {"lat": 35.43333, "lon": 139.65}}, {"facility": "1245.52.084 Boehringer Ingelheim Investigational Site", "city": "Yokohama, Kanagawa", "country": "Japan", "geoPoint": {"lat": 35.43333, "lon": 139.65}}]}, "referencesModule": {"references": [{"pmid": "28753486", "type": "DERIVED", "citation": "Shiba T, Ishii S, Okamura T, Mitsuyoshi R, Pfarr E, Koiwai K. Efficacy and safety of empagliflozin in Japanese patients with type 2 diabetes mellitus: A sub-analysis by body mass index and age of pooled data from three clinical trials. Diabetes Res Clin Pract. 2017 Sep;131:169-178. doi: 10.1016/j.diabres.2017.07.004. Epub 2017 Jul 8."}, {"pmid": "25772548", "type": "DERIVED", "citation": "Araki E, Tanizawa Y, Tanaka Y, Taniguchi A, Koiwai K, Kim G, Salsali A, Woerle HJ, Broedl UC. Long-term treatment with empagliflozin as add-on to oral antidiabetes therapy in Japanese patients with type 2 diabetes mellitus. Diabetes Obes Metab. 2015 Jul;17(7):665-74. doi: 10.1111/dom.12464. Epub 2015 Apr 15."}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Sulfonylurea: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Sulfonylurea"}, {"id": "FG001", "title": "Sulfonylurea: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Sulfonylurea"}, {"id": "FG002", "title": "Sulfonylurea: Metformin", "description": "250mg tablet of metformin twice daily for 52 weeks, as an open-label treatment, for patients with background treatment of Sulfonylurea"}, {"id": "FG003", "title": "Biguanide: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Biguanide"}, {"id": "FG004", "title": "Biguanide: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Biguanide"}, {"id": "FG005", "title": "Thiazolidinedione: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Thiazolidinedione"}, {"id": "FG006", "title": "Thiazolidinedione: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Thiazolidinedione"}, {"id": "FG007", "title": "Alpha Glucosidase Inhibitor: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Alpha glucosidase inhibitor"}, {"id": "FG008", "title": "Alpha Glucosidase Inhibitor: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Alpha glucosidase inhibitor"}, {"id": "FG009", "title": "DPP-IV Inhibitor: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of dipeptidyl peptidase IV (DPP-IV) inhibitor"}, {"id": "FG010", "title": "DPP-IV Inhibitor: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of dipeptidyl peptidase IV (DPP-IV) inhibitor"}, {"id": "FG011", "title": "Glinide: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Glinide"}, {"id": "FG012", "title": "Glinide: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Glinide"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "136"}, {"groupId": "FG001", "numSubjects": "137"}, {"groupId": "FG002", "numSubjects": "63"}, {"groupId": "FG003", "numSubjects": "68"}, {"groupId": "FG004", "numSubjects": "65"}, {"groupId": "FG005", "numSubjects": "137"}, {"groupId": "FG006", "numSubjects": "136"}, {"groupId": "FG007", "numSubjects": "69"}, {"groupId": "FG008", "numSubjects": "70"}, {"groupId": "FG009", "numSubjects": "68"}, {"groupId": "FG010", "numSubjects": "71"}, {"groupId": "FG011", "numSubjects": "70"}, {"groupId": "FG012", "numSubjects": "70"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "126"}, {"groupId": "FG001", "numSubjects": "128"}, {"groupId": "FG002", "numSubjects": "59"}, {"groupId": "FG003", "numSubjects": "63"}, {"groupId": "FG004", "numSubjects": "63"}, {"groupId": "FG005", "numSubjects": "127"}, {"groupId": "FG006", "numSubjects": "124"}, {"groupId": "FG007", "numSubjects": "62"}, {"groupId": "FG008", "numSubjects": "62"}, {"groupId": "FG009", "numSubjects": "58"}, {"groupId": "FG010", "numSubjects": "62"}, {"groupId": "FG011", "numSubjects": "67"}, {"groupId": "FG012", "numSubjects": "63"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "10"}, {"groupId": "FG001", "numSubjects": "9"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "5"}, {"groupId": "FG004", "numSubjects": "2"}, {"groupId": "FG005", "numSubjects": "10"}, {"groupId": "FG006", "numSubjects": "12"}, {"groupId": "FG007", "numSubjects": "7"}, {"groupId": "FG008", "numSubjects": "8"}, {"groupId": "FG009", "numSubjects": "10"}, {"groupId": "FG010", "numSubjects": "9"}, {"groupId": "FG011", "numSubjects": "3"}, {"groupId": "FG012", "numSubjects": "7"}]}], "dropWithdraws": [{"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "4"}, {"groupId": "FG002", "numSubjects": "3"}, {"groupId": "FG003", "numSubjects": "2"}, {"groupId": "FG004", "numSubjects": "2"}, {"groupId": "FG005", "numSubjects": "5"}, {"groupId": "FG006", "numSubjects": "6"}, {"groupId": "FG007", "numSubjects": "2"}, {"groupId": "FG008", "numSubjects": "3"}, {"groupId": "FG009", "numSubjects": "5"}, {"groupId": "FG010", "numSubjects": "6"}, {"groupId": "FG011", "numSubjects": "1"}, {"groupId": "FG012", "numSubjects": "3"}]}, {"type": "Lack of Efficacy", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "0"}, {"groupId": "FG007", "numSubjects": "2"}, {"groupId": "FG008", "numSubjects": "0"}, {"groupId": "FG009", "numSubjects": "0"}, {"groupId": "FG010", "numSubjects": "0"}, {"groupId": "FG011", "numSubjects": "0"}, {"groupId": "FG012", "numSubjects": "0"}]}, {"type": "Protocol Violation", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "1"}, {"groupId": "FG006", "numSubjects": "0"}, {"groupId": "FG007", "numSubjects": "1"}, {"groupId": "FG008", "numSubjects": "0"}, {"groupId": "FG009", "numSubjects": "0"}, {"groupId": "FG010", "numSubjects": "0"}, {"groupId": "FG011", "numSubjects": "0"}, {"groupId": "FG012", "numSubjects": "0"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "0"}, {"groupId": "FG007", "numSubjects": "0"}, {"groupId": "FG008", "numSubjects": "0"}, {"groupId": "FG009", "numSubjects": "0"}, {"groupId": "FG010", "numSubjects": "0"}, {"groupId": "FG011", "numSubjects": "0"}, {"groupId": "FG012", "numSubjects": "1"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "4"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "3"}, {"groupId": "FG006", "numSubjects": "4"}, {"groupId": "FG007", "numSubjects": "2"}, {"groupId": "FG008", "numSubjects": "5"}, {"groupId": "FG009", "numSubjects": "4"}, {"groupId": "FG010", "numSubjects": "3"}, {"groupId": "FG011", "numSubjects": "2"}, {"groupId": "FG012", "numSubjects": "0"}]}, {"type": "Other reason not defined above", "reasons": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "1"}, {"groupId": "FG006", "numSubjects": "2"}, {"groupId": "FG007", "numSubjects": "0"}, {"groupId": "FG008", "numSubjects": "0"}, {"groupId": "FG009", "numSubjects": "1"}, {"groupId": "FG010", "numSubjects": "0"}, {"groupId": "FG011", "numSubjects": "0"}, {"groupId": "FG012", "numSubjects": "3"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Sulfonylurea: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Sulfonylurea"}, {"id": "BG001", "title": "Sulfonylurea: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Sulfonylurea"}, {"id": "BG002", "title": "Sulfonylurea: Metformin", "description": "250mg tablet of metformin twice daily for 52 weeks, as an open-label treatment, for patients with background treatment of Sulfonylurea"}, {"id": "BG003", "title": "Biguanide: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Biguanide"}, {"id": "BG004", "title": "Biguanide: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Biguanide"}, {"id": "BG005", "title": "Thiazolidinedione: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Thiazolidinedione"}, {"id": "BG006", "title": "Thiazolidinedione: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Thiazolidinedione"}, {"id": "BG007", "title": "Alpha Glucosidase Inhibitor: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Alpha glucosidase inhibitor"}, {"id": "BG008", "title": "Alpha Glucosidase Inhibitor: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Alpha glucosidase inhibitor"}, {"id": "BG009", "title": "DPP-IV Inhibitor: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of DPP-IV inhibitor"}, {"id": "BG010", "title": "DPP-IV Inhibitor: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of DPP-IV inhibitor"}, {"id": "BG011", "title": "Glinide: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Glinide"}, {"id": "BG012", "title": "Glinide: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Glinide"}, {"id": "BG013", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "136"}, {"groupId": "BG001", "value": "137"}, {"groupId": "BG002", "value": "63"}, {"groupId": "BG003", "value": "68"}, {"groupId": "BG004", "value": "65"}, {"groupId": "BG005", "value": "137"}, {"groupId": "BG006", "value": "136"}, {"groupId": "BG007", "value": "69"}, {"groupId": "BG008", "value": "70"}, {"groupId": "BG009", "value": "68"}, {"groupId": "BG010", "value": "71"}, {"groupId": "BG011", "value": "70"}, {"groupId": "BG012", "value": "70"}, {"groupId": "BG013", "value": "1160"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "61.3", "spread": "9.9"}, {"groupId": "BG001", "value": "61.8", "spread": "9.6"}, {"groupId": "BG002", "value": "60.0", "spread": "10.2"}, {"groupId": "BG003", "value": "56.9", "spread": "9.5"}, {"groupId": "BG004", "value": "57.3", "spread": "11.4"}, {"groupId": "BG005", "value": "60.4", "spread": "10.1"}, {"groupId": "BG006", "value": "59.7", "spread": "9.9"}, {"groupId": "BG007", "value": "63.5", "spread": "8.8"}, {"groupId": "BG008", "value": "61.9", "spread": "11.7"}, {"groupId": "BG009", "value": "63.3", "spread": "9.9"}, {"groupId": "BG010", "value": "59.1", "spread": "10.3"}, {"groupId": "BG011", "value": "59.2", "spread": "12.1"}, {"groupId": "BG012", "value": "57.7", "spread": "11.8"}, {"groupId": "BG013", "value": "60.3", "spread": "10.4"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "37"}, {"groupId": "BG001", "value": "41"}, {"groupId": "BG002", "value": "16"}, {"groupId": "BG003", "value": "30"}, {"groupId": "BG004", "value": "22"}, {"groupId": "BG005", "value": "23"}, {"groupId": "BG006", "value": "34"}, {"groupId": "BG007", "value": "18"}, {"groupId": "BG008", "value": "18"}, {"groupId": "BG009", "value": "27"}, {"groupId": "BG010", "value": "23"}, {"groupId": "BG011", "value": "23"}, {"groupId": "BG012", "value": "13"}, {"groupId": "BG013", "value": "325"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "99"}, {"groupId": "BG001", "value": "96"}, {"groupId": "BG002", "value": "47"}, {"groupId": "BG003", "value": "38"}, {"groupId": "BG004", "value": "43"}, {"groupId": "BG005", "value": "114"}, {"groupId": "BG006", "value": "102"}, {"groupId": "BG007", "value": "51"}, {"groupId": "BG008", "value": "52"}, {"groupId": "BG009", "value": "41"}, {"groupId": "BG010", "value": "48"}, {"groupId": "BG011", "value": "47"}, {"groupId": "BG012", "value": "57"}, {"groupId": "BG013", "value": "835"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "SECONDARY", "title": "Change From Baseline in HbA1c", "description": "Change from baseline in HbA1c after 52 weeks of treatment", "populationDescription": "Full analysis set", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "percentage of HbA1c", "timeFrame": "Baseline and 52 weeks", "groups": [{"id": "OG000", "title": "Sulfonylurea: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Sulfonylurea"}, {"id": "OG001", "title": "Sulfonylurea: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Sulfonylurea"}, {"id": "OG002", "title": "Sulfonylurea: Metformin", "description": "250mg tablet of metformin twice daily for 52 weeks, as an open-label treatment, for patients with background treatment of Sulfonylurea"}, {"id": "OG003", "title": "Biguanide: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Biguanide"}, {"id": "OG004", "title": "Biguanide: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Biguanide"}, {"id": "OG005", "title": "Thiazolidinedione: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Thiazolidinedione"}, {"id": "OG006", "title": "Thiazolidinedione: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Thiazolidinedione"}, {"id": "OG007", "title": "Alpha Glucosidase Inhibitor: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Alpha glucosidase inhibitor"}, {"id": "OG008", "title": "Alpha Glucosidase Inhibitor: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Alpha glucosidase inhibitor"}, {"id": "OG009", "title": "DPP-IV Inhibitor: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of DPP-IV inhibitor"}, {"id": "OG010", "title": "DPP-IV Inhibitor: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of DPP-IV inhibitor"}, {"id": "OG011", "title": "Glinide: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Glinide"}, {"id": "OG012", "title": "Glinide: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Glinide"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "136"}, {"groupId": "OG001", "value": "137"}, {"groupId": "OG002", "value": "63"}, {"groupId": "OG003", "value": "68"}, {"groupId": "OG004", "value": "65"}, {"groupId": "OG005", "value": "137"}, {"groupId": "OG006", "value": "136"}, {"groupId": "OG007", "value": "69"}, {"groupId": "OG008", "value": "70"}, {"groupId": "OG009", "value": "68"}, {"groupId": "OG010", "value": "71"}, {"groupId": "OG011", "value": "70"}, {"groupId": "OG012", "value": "70"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.93", "spread": "0.05"}, {"groupId": "OG001", "value": "-0.96", "spread": "0.05"}, {"groupId": "OG002", "value": "-0.97", "spread": "0.08"}, {"groupId": "OG003", "value": "-0.81", "spread": "0.06"}, {"groupId": "OG004", "value": "-0.98", "spread": "0.06"}, {"groupId": "OG005", "value": "-0.90", "spread": "0.05"}, {"groupId": "OG006", "value": "-0.96", "spread": "0.05"}, {"groupId": "OG007", "value": "-0.87", "spread": "0.06"}, {"groupId": "OG008", "value": "-0.77", "spread": "0.06"}, {"groupId": "OG009", "value": "-1.00", "spread": "0.06"}, {"groupId": "OG010", "value": "-0.83", "spread": "0.06"}, {"groupId": "OG011", "value": "-0.98", "spread": "0.08"}, {"groupId": "OG012", "value": "-0.98", "spread": "0.08"}]}]}]}, {"type": "PRIMARY", "title": "Number of Patients With Drug Related Adverse Events", "description": "Number of Patients With Drug Related Adverse Events after the first drug intake until 7 days after the last treatment administration, up to 383 days", "populationDescription": "Treated patients", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "After the first drug intake until 7 days after the last treatment administration, up to 383 days", "groups": [{"id": "OG000", "title": "Sulfonylurea: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Sulfonylurea"}, {"id": "OG001", "title": "Sulfonylurea: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Sulfonylurea"}, {"id": "OG002", "title": "Sulfonylurea: Metformin", "description": "250mg tablet of metformin twice daily for 52 weeks, as an open-label treatment, for patients with background treatment of Sulfonylurea"}, {"id": "OG003", "title": "Biguanide: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Biguanide"}, {"id": "OG004", "title": "Biguanide: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Biguanide"}, {"id": "OG005", "title": "Thiazolidinedione: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Thiazolidinedione"}, {"id": "OG006", "title": "Thiazolidinedione: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Thiazolidinedione"}, {"id": "OG007", "title": "Alpha Glucosidase Inhibitor: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Alpha glucosidase inhibitor"}, {"id": "OG008", "title": "Alpha Glucosidase Inhibitor: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Alpha glucosidase inhibitor"}, {"id": "OG009", "title": "DPP-IV Inhibitor: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of DPP-IV inhibitor"}, {"id": "OG010", "title": "DPP-IV Inhibitor: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of DPP-IV inhibitor"}, {"id": "OG011", "title": "Glinide: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Glinide"}, {"id": "OG012", "title": "Glinide: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Glinide"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "136"}, {"groupId": "OG001", "value": "137"}, {"groupId": "OG002", "value": "63"}, {"groupId": "OG003", "value": "68"}, {"groupId": "OG004", "value": "65"}, {"groupId": "OG005", "value": "137"}, {"groupId": "OG006", "value": "136"}, {"groupId": "OG007", "value": "69"}, {"groupId": "OG008", "value": "70"}, {"groupId": "OG009", "value": "68"}, {"groupId": "OG010", "value": "71"}, {"groupId": "OG011", "value": "70"}, {"groupId": "OG012", "value": "70"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "19"}, {"groupId": "OG001", "value": "25"}, {"groupId": "OG002", "value": "13"}, {"groupId": "OG003", "value": "13"}, {"groupId": "OG004", "value": "9"}, {"groupId": "OG005", "value": "20"}, {"groupId": "OG006", "value": "19"}, {"groupId": "OG007", "value": "7"}, {"groupId": "OG008", "value": "5"}, {"groupId": "OG009", "value": "9"}, {"groupId": "OG010", "value": "18"}, {"groupId": "OG011", "value": "9"}, {"groupId": "OG012", "value": "9"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Confirmed Hypoglycaemic Adverse Events", "description": "Number of patients with confirmed hypoglycaemic adverse events", "populationDescription": "Treated patients", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "After the first drug intake until 7 days after the last treatment administration, up to 383 days", "groups": [{"id": "OG000", "title": "Sulfonylurea: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Sulfonylurea"}, {"id": "OG001", "title": "Sulfonylurea: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Sulfonylurea"}, {"id": "OG002", "title": "Sulfonylurea: Metformin", "description": "250mg tablet of metformin twice daily for 52 weeks, as an open-label treatment, for patients with background treatment of Sulfonylurea"}, {"id": "OG003", "title": "Biguanide: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Biguanide"}, {"id": "OG004", "title": "Biguanide: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Biguanide"}, {"id": "OG005", "title": "Thiazolidinedione: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Thiazolidinedione"}, {"id": "OG006", "title": "Thiazolidinedione: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Thiazolidinedione"}, {"id": "OG007", "title": "Alpha Glucosidase Inhibitor: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Alpha glucosidase inhibitor"}, {"id": "OG008", "title": "Alpha Glucosidase Inhibitor: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Alpha glucosidase inhibitor"}, {"id": "OG009", "title": "DPP-IV Inhibitor: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of DPP-IV inhibitor"}, {"id": "OG010", "title": "DPP-IV Inhibitor: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of DPP-IV inhibitor"}, {"id": "OG011", "title": "Glinide: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Glinide"}, {"id": "OG012", "title": "Glinide: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Glinide"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "136"}, {"groupId": "OG001", "value": "137"}, {"groupId": "OG002", "value": "63"}, {"groupId": "OG003", "value": "68"}, {"groupId": "OG004", "value": "65"}, {"groupId": "OG005", "value": "137"}, {"groupId": "OG006", "value": "136"}, {"groupId": "OG007", "value": "69"}, {"groupId": "OG008", "value": "70"}, {"groupId": "OG009", "value": "68"}, {"groupId": "OG010", "value": "71"}, {"groupId": "OG011", "value": "70"}, {"groupId": "OG012", "value": "70"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "9"}, {"groupId": "OG002", "value": "5"}, {"groupId": "OG003", "value": "0"}, {"groupId": "OG004", "value": "1"}, {"groupId": "OG005", "value": "2"}, {"groupId": "OG006", "value": "1"}, {"groupId": "OG007", "value": "0"}, {"groupId": "OG008", "value": "0"}, {"groupId": "OG009", "value": "0"}, {"groupId": "OG010", "value": "1"}, {"groupId": "OG011", "value": "0"}, {"groupId": "OG012", "value": "2"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "After the first drug intake until 7 days after the last treatment administration, up to 383 days", "eventGroups": [{"id": "EG000", "title": "Sulfonylurea: Empa 10mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Sulfonylurea", "seriousNumAffected": 10, "seriousNumAtRisk": 136, "otherNumAffected": 73, "otherNumAtRisk": 136}, {"id": "EG001", "title": "Sulfonylurea: Empa 25mg", "description": "One tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Sulfonylurea", "seriousNumAffected": 7, "seriousNumAtRisk": 137, "otherNumAffected": 74, "otherNumAtRisk": 137}, {"id": "EG002", "title": "Sulfonylurea: Metformin", "description": "250mg tablet of metformin twice daily for 52 weeks, as an open-label treatment, for patients with background treatment of Sulfonylurea", "seriousNumAffected": 3, "seriousNumAtRisk": 63, "otherNumAffected": 44, "otherNumAtRisk": 63}, {"id": "EG003", "title": "Biguanide: Empa 10mg", "description": "tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Biguanide", "seriousNumAffected": 7, "seriousNumAtRisk": 68, "otherNumAffected": 32, "otherNumAtRisk": 68}, {"id": "EG004", "title": "Biguanide: Empa 25mg", "description": "tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Biguanide", "seriousNumAffected": 2, "seriousNumAtRisk": 65, "otherNumAffected": 35, "otherNumAtRisk": 65}, {"id": "EG005", "title": "Thiazolidinedione: Empa 10mg", "description": "tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Thiazolidinedione", "seriousNumAffected": 12, "seriousNumAtRisk": 137, "otherNumAffected": 77, "otherNumAtRisk": 137}, {"id": "EG006", "title": "Thiazolidinedione: Empa 25mg", "description": "tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Thiazolidinedione", "seriousNumAffected": 12, "seriousNumAtRisk": 136, "otherNumAffected": 74, "otherNumAtRisk": 136}, {"id": "EG007", "title": "Alpha-GI: Empa 10mg", "description": "tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Alpha-GI", "seriousNumAffected": 2, "seriousNumAtRisk": 69, "otherNumAffected": 40, "otherNumAtRisk": 69}, {"id": "EG008", "title": "Alpha-GI: Empa 25mg", "description": "tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Alpha-GI", "seriousNumAffected": 5, "seriousNumAtRisk": 70, "otherNumAffected": 34, "otherNumAtRisk": 70}, {"id": "EG009", "title": "DPP-4 Inhibitor: Empa 10mg", "description": "tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of DPP-4 inhibitor", "seriousNumAffected": 7, "seriousNumAtRisk": 68, "otherNumAffected": 37, "otherNumAtRisk": 68}, {"id": "EG010", "title": "DPP-4 Inhibitor: Empa 25mg", "description": "tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of DPP-4 inhibitor", "seriousNumAffected": 5, "seriousNumAtRisk": 71, "otherNumAffected": 36, "otherNumAtRisk": 71}, {"id": "EG011", "title": "Glinide: Empa 10mg", "description": "tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Glinide", "seriousNumAffected": 1, "seriousNumAtRisk": 70, "otherNumAffected": 30, "otherNumAtRisk": 70}, {"id": "EG012", "title": "Glinide: Empa 25mg", "description": "tablet of empagliflozin (empa) once daily for 52 weeks as an add-on therapy for patients with a background treatment of Glinide", "seriousNumAffected": 4, "seriousNumAtRisk": 70, "otherNumAffected": 38, "otherNumAtRisk": 70}], "seriousEvents": [{"term": "Urinary tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Cellulitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 1, "numAtRisk": 70}]}, {"term": "Febrile infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Gangrene", "organSystem": "Infections and infestations", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 1, "numAtRisk": 70}]}, {"term": "Osteomyelitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 1, "numAtRisk": 70}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Pulmonary tuberculosis", "organSystem": "Infections and infestations", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Pyelonephritis", "organSystem": "Infections and infestations", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Colon cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 1, "numAtRisk": 70}]}, {"term": "Gastric cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Lung neoplasm malignant", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Benign ovarian tumour", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Prostate cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 1, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Meningioma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Oropharyngeal cancer stage unspecified", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 1, "numAtRisk": 70}]}, {"term": "Uterine cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 1, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Rectal cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Small cell lung cancer stage unspecified", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Anaemia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 1, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Anaphylactic reaction", "organSystem": "Immune system disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 1, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Schizophrenia", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 1, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Lacunar infarction", "organSystem": "Nervous system disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 1, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Carotid artery stenosis", "organSystem": "Nervous system disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Cerebral arteriosclerosis", "organSystem": "Nervous system disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Cerebral infarction", "organSystem": "Nervous system disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Transient ischaemic attack", "organSystem": "Nervous system disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "VIIth nerve paralysis", "organSystem": "Nervous system disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Cataract", "organSystem": "Eye disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 1, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Glaucoma", "organSystem": "Eye disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 1, "numAtRisk": 70}]}, {"term": "Retinal detachment", "organSystem": "Eye disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Acute myocardial infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 1, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Congestive cardiomyopathy", "organSystem": "Cardiac disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Coronary artery stenosis", "organSystem": "Cardiac disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Myocardial infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 1, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Prinzmetal angina", "organSystem": "Cardiac disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Angina pectoris", "organSystem": "Cardiac disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Arteriosclerosis coronary artery", "organSystem": "Cardiac disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Atrial fibrillation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Cardiac failure congestive", "organSystem": "Cardiac disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Embolism arterial", "organSystem": "Vascular disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 1, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Artery dissection", "organSystem": "Vascular disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Peripheral arterial occlusive disease", "organSystem": "Vascular disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Hyperventilation", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Sleep apnoea syndrome", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Anal fissure", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 1, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Gastrointestinal haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 1, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Haemorrhoids", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Inguinal hernia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Colitis ischaemic", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Colonic polyp", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Duodenitis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Leukoplakia oral", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Megacolon", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Melaena", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Drug-induced liver injury", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Intervertebral disc protrusion", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 1, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Lumbar spinal stenosis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Polyarthritis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 1, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Rotator cuff syndrome", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Spinal column stenosis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Bladder prolapse", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 1, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Calculus ureteric", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Diabetic nephropathy", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Nephrolithiasis", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Benign prostatic hyperplasia", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 1, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Chest pain", "organSystem": "General disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Femur fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 1, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Ankle fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Heat illness", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Pelvic fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Subdural haematoma", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}], "otherEvents": [{"term": "Nasopharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 41, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 38, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 26, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 12, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 23, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 44, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 37, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 26, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 21, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 23, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 15, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 16, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 17, "numAtRisk": 70}]}, {"term": "Influenza", "organSystem": "Infections and infestations", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 3, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 2, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 1, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 3, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 2, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 2, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 2, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 3, "numAtRisk": 70}]}, {"term": "Pharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 7, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 6, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 6, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 2, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 2, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 5, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 2, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 5, "numAtRisk": 70}]}, {"term": "Vulvovaginal candidiasis", "organSystem": "Infections and infestations", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 4, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 2, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 2, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 3, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Gastroenteritis", "organSystem": "Infections and infestations", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 2, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 4, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 1, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 4, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 1, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 1, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 2, "numAtRisk": 70}]}, {"term": "Bronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 7, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 3, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 3, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 2, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 5, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 1, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 2, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 3, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 1, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 3, "numAtRisk": 70}]}, {"term": "Hypoglycaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 11, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 12, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 2, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 3, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 4, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 2, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 3, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 3, "numAtRisk": 70}]}, {"term": "Dizziness", "organSystem": "Nervous system disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 4, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 4, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 4, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 3, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 1, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 3, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 2, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 6, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 2, "numAtRisk": 70}]}, {"term": "Upper respiratory tract inflammation", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 7, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 3, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 3, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 1, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 2, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 1, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 1, "numAtRisk": 70}]}, {"term": "Constipation", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 4, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 3, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 9, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 1, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 1, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 8, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 5, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 7, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 3, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Diarrhoea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 6, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 4, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 5, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 2, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 2, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 4, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 1, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 1, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 1, "numAtRisk": 70}]}, {"term": "Gastritis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 4, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 2, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 2, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 4, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 1, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 2, "numAtRisk": 70}]}, {"term": "Back pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 7, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 5, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 8, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 8, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 2, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 1, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 1, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 5, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 4, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 3, "numAtRisk": 70}]}, {"term": "Pollakiuria", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 2, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 11, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 3, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 2, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 3, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 4, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 7, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 3, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 5, "numAtRisk": 70}]}, {"term": "Thirst", "organSystem": "General disorders", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 4, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 0, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 0, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 2, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 0, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 0, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 1, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 0, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 2, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 0, "numAtRisk": 70}]}, {"term": "Fall", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 2, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 9, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 8, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 3, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 2, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 4, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 4, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 3, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 2, "numAtRisk": 70}]}, {"term": "Contusion", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MEDDRA 15.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 136}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 137}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 63}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 68}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 65}, {"groupId": "EG005", "numAffected": 2, "numAtRisk": 137}, {"groupId": "EG006", "numAffected": 5, "numAtRisk": 136}, {"groupId": "EG007", "numAffected": 2, "numAtRisk": 69}, {"groupId": "EG008", "numAffected": 4, "numAtRisk": 70}, {"groupId": "EG009", "numAffected": 2, "numAtRisk": 68}, {"groupId": "EG010", "numAffected": 4, "numAtRisk": 71}, {"groupId": "EG011", "numAffected": 1, "numAtRisk": 70}, {"groupId": "EG012", "numAffected": 1, "numAtRisk": 70}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract."}, "pointOfContact": {"title": "Boehringer Ingelheim Call Center", "organization": "Boehringer Ingelheim Pharmaceuticals", "email": "clintriage.rdg@boehringer-ingelheim.com", "phone": "1-800-243-0127"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000003920", "term": "Diabetes Mellitus"}, {"id": "D000003924", "term": "Diabetes Mellitus, Type 2"}], "ancestors": [{"id": "D000044882", "term": "Glucose Metabolism Disorders"}, {"id": "D000008659", "term": "Metabolic Diseases"}, {"id": "D000004700", "term": "Endocrine System Diseases"}], "browseLeaves": [{"id": "M7115", "name": "Diabetes Mellitus", "asFound": "Diabetes Mellitus", "relevance": "HIGH"}, {"id": "M7119", "name": "Diabetes Mellitus, Type 2", "asFound": "Diabetes Mellitus, Type 2", "relevance": "HIGH"}, {"id": "M9115", "name": "Glycogen Storage Disease Type II", "relevance": "LOW"}, {"id": "M11639", "name": "Metabolic Diseases", "relevance": "LOW"}, {"id": "M25403", "name": "Glucose Metabolism Disorders", "relevance": "LOW"}, {"id": "M7862", "name": "Endocrine System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC18", "name": "Nutritional and Metabolic Diseases"}, {"abbrev": "BC19", "name": "Gland and Hormone Related Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC10", "name": "Nervous System Diseases"}, {"abbrev": "BC16", "name": "Diseases and Abnormalities at or Before Birth"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000008687", "term": "Metformin"}, {"id": "C000570240", "term": "Empagliflozin"}], "ancestors": [{"id": "D000007004", "term": "Hypoglycemic Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000077203", "term": "Sodium-Glucose Transporter 2 Inhibitors"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}], "browseLeaves": [{"id": "M258082", "name": "Empagliflozin", "asFound": "Thalidomide", "relevance": "HIGH"}, {"id": "M11667", "name": "Metformin", "asFound": "Assessment", "relevance": "HIGH"}, {"id": "M10054", "name": "Hypoglycemic Agents", "relevance": "LOW"}, {"id": "M27957", "name": "Dipeptidyl-Peptidase IV Inhibitors", "relevance": "LOW"}, {"id": "M4931", "name": "Biguanides", "relevance": "LOW"}, {"id": "M244708", "name": "2,4-thiazolidinedione", "relevance": "LOW"}, {"id": "M1691", "name": "Sodium-Glucose Transporter 2 Inhibitors", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Hypo", "name": "Hypoglycemic Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}